Drugmaker Novartis announced it’s cutting more than 2,000 jobs — most of them in Europe — as part of a global restructuring. The company plans to focus on producing and selling more innovative drugs, but these specified medicines require lots of research and carry higher price tags.
Click the audio player above to hear the full story.
44 minutes ago25:22
8 hours ago7:09
13 hours ago30:57
13 hours ago12:45
6 days ago28:44
4 months ago24:33